Back to top
more

Alkermes (ALKS)

(Delayed Data from NSDQ)

$23.76 USD

23.76
1,798,839

-0.25 (-1.04%)

Updated Apr 18, 2024 04:00 PM ET

After-Market: $23.78 +0.02 (0.08%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy18.00%
3Hold9.44%
4Sell5.10%
5Strong Sell2.53%
S&P50011.08%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth D Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 33% (82 out of 251)

Industry: Medical - Biomedical and Genetics

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for ALKS

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

Fiscal Year End for Alkermes plc falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 773 608 536 635 535
Receivables 332 288 313 275 257
Notes Receivable 0 0 0 0 0
Inventories 186 181 150 126 102
Other Current Assets 193 52 62 75 68
Total Current Assets 1,486 1,130 1,062 1,111 962
Net Property & Equipment 227 325 341 350 362
Investments & Advances 40 132 229 25 79
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 196 116 82 86 97
Intangibles 85 131 167 204 244
Deposits & Other Assets 12 15 27 42 49
Total Assets 2,136 1,964 2,024 1,950 1,805
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 0 0 0 0 0
Accounts Payable 241 220 446 412 373
Current Portion Long-Term Debt 3 3 3 3 3
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 264 252 0 0 0
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 7 7 6 8 7
Total Current Liabilities 520 498 471 438 391
Mortgages 0 0 0 0 0
Deferred Taxes/Income 0 0 11 16 22
Convertible Debt 0 0 0 0 0
Long-Term Debt 288 290 293 272 274
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 50 42 32 37 27
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 934 920 912 883 720
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 2 2 2 2 2
Capital Surplus 2,737 2,913 2,798 2,686 2,586
Retained Earnings -1,344 -1,699 -1,541 -1,493 -1,382
Other Equity -3 -11 -4 -1 -2
Treasury Stock 189 161 143 126 118
Total Shareholder's Equity 1,203 1,044 1,113 1,067 1,085
Total Liabilities & Shareholder's Equity 2,136 1,964 2,024 1,950 1,805
Total Common Equity 1,203 1,044 1,113 1,067 1,085
Shares Outstanding 166.80 164.30 161.70 159.10 157.50
Book Value Per Share 7.21 6.35 6.88 6.71 6.89

Fiscal Year End for Alkermes plc falls in the month of December.

All items in Millions except Per Share data.

3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Assets          
Cash & Equivalents -99,999 773 889 829 600
Receivables NA 332 338 334 269
Notes Receivable NA 0 0 0 0
Inventories NA 186 192 189 185
Other Current Assets NA 193 46 44 55
Total Current Assets NA 1,486 1,465 1,397 1,110
Net Property & Equipment NA 227 328 324 321
Investments & Advances NA 40 106 78 92
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 196 162 153 151
Intangibles NA 85 104 113 122
Deposits & Other Assets NA 12 11 15 15
Total Assets NA 2,136 2,279 2,187 1,923
Liabilities & Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Notes Payable NA 0 0 0 0
Accounts Payable NA 241 243 243 190
Current Portion Long-Term Debt NA 3 3 3 3
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 264 238 223 282
Income Taxes Payable NA 0 0 0 0
Other Current Liabilities NA 7 3 3 2
Total Current Liabilities NA 520 503 487 493
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 0 0 0 0
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 288 288 289 290
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 54 48 48
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 934 924 907 917
Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 2 2 2 2
Capital Surplus NA 2,737 3,003 2,976 2,939
Retained Earnings NA -1,344 -1,456 -1,504 -1,741
Other Equity NA -3 -6 -7 -8
Treasury Stock NA 189 187 186 186
Total Shareholder's Equity NA 1,203 1,356 1,280 1,006
Total Liabilities & Shareholder's Equity NA 2,136 2,279 2,187 1,923
Total Common Equity 0 1,203 1,356 1,280 1,006
Shares Outstanding 167.00 166.80 166.80 166.50 166.10
Book Value Per Share 0.00 7.21 8.13 7.69 6.05